Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Pairwise is a purpose-driven food+tech company dedicated to building a healthier world through better fruits and vegetables.
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Petfolk provides modern veterinary care through in-person and virtual services.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Atlas Data Storage is an information technology company focused on data storage solutions.
Lomond Therapeutics creates pharmacological platforms that target escape mutations.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Perceive Pharma operates as a pharmaceutical company.
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
Actio Biosciences is a research center that develops drugs for rare diseases.
myLaurel offers in-home care, telemedicine, and extended follow-up services to reduce hospitalizations and re-admissions.
Cohere Health is a SaaS company that focuses on improving the efficiency and effectiveness of healthcare delivery.
Ascertain empowers care teams with AI to reduce admin burden and streamline operations for health systems, payers & providers.
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Nema provides comprehensive trauma care administered by PTSD-trained therapists.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
Intus Care develops healthcare analytics platform to improve care and reduce hospitalizations for patients.
Deerfield Management has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield Management's top investment sectors include Health Care, Biotechnology, Medical, Biopharma, Life Science. The firm invests across 35 different industry categories.
Among tracked funding rounds, BBOT received $200.0M in a Venture - Series Unknown round. Deerfield Management's total known invested capital is $1.8B.
Deerfield Management's average investment size is $44.0M across its portfolio of 42 companies.
Recent Deerfield Management portfolio additions include Pairwise Plants, Spectrawave, Petfolk, Frontier Medicines, R3 Vascular. These companies were founded in 2020 or later.